Last reviewed · How we verify
NCT04873570: BE
Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects
Phase 1 trial testing Moxifloxacin 400mg in Healthy Individuals in 38 participants. Completed in 10 June 2021.
8 June 2021
Quick facts
| Lead sponsor | University of Karachi |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 38 |
| Start date | 28 May 2021 |
| Primary completion | 8 June 2021 |
| Estimated completion | 10 June 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Moxifloxacin 400mg — full drug profile →
Conditions studied
- Healthy Individuals — all drugs for Healthy Individuals →
- Bioequivalence Study — all drugs for Bioequivalence Study →
Sponsor
University of Karachi
Who can join
Adults 18 to 55, male only, with Healthy Individuals or Bioequivalence Study. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single oral dose, of test and reference Tablet will be administered to healthy volunteers, after at least 10 hours fast together with 240 mL of ambient temperature water at their scheduled dosing time-points. Blood samples will be taken up to 72.0 hours post-dose.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04873570
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Moxifloxacin 400mg
Trials testing the same drug.
- NCT06310876 — A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects · Phase 1 · completed
- NCT05830071 — A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV) · Phase 1 · completed
- NCT04966325 — Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects · EARLY_PHASE1 · completed
- NCT04692623 — EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY · Phase 1 · completed
- NCT04255277 — To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cener · Phase 1 · completed
Other recruiting trials for Healthy Individuals
Currently open trials in the same condition.
- NCT07340385 — Physiological and Biochemical Responses to Blood Flow Restriction Training · recruiting
- NCT07287306 — Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals · NA · recruiting
- NCT07047300 — Effect of Heel Lift Insole on Kinematics and Kinetics of the Lower Limb and Lumbar Spine Among Healthy Individuals · recruiting
- NCT06711614 — FIRE-Diet: Food as an Intervention to Reduce the Effects of Woodsmoke Exposure on Respiratory Health · NA · recruiting
- NCT06428526 — Impact of Sensory Electrical Stimulation on Sensation and Tremor · NA · active not recruiting
Other University of Karachi trials
Trials by the same sponsor.
- NCT07496099 — Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome · NA · not yet recruiting
- NCT07396233 — Effects of Diagonal Proprioceptive Neuromuscular Facilitation Patterns on Pain and Functional Outcomes in Patients With · NA · recruiting
- NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
- NCT07205042 — Walking for Hypothyroidism Trial (WHT) · NA · not yet recruiting
- NCT06960330 — Wearable Biofeedback Devices for Remote Physiotherapy and Rehabilitation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04873570 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Karachi
- Last refreshed: 7 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04873570.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing